INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Renovaro

New York, New York--(Newsfile Corp. - March 10, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Renovaro Biosciences Inc. ("Renovaro" or the "Company") (NASDAQ: RENB).

If you suffered significant losses in Renovaro stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/RENB.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

On February 13, 2024, Hindenburg Research published a report alleging that in the months leading up to the vote on Renovaro's merger with GEDi Cube, "Renovaro enlisted stock promoters, including one previously sanctioned by the SEC, to hype up the GEDi deal and pump shares to retail investors." Following this news, the price of the Company's stock dropped.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201071